Walvax BioTech Capital Reinvestment Ratio
Walvax BioTech capital reinvestment ratio. Walvax BioTech (300142) has a Capital Reinvestment Ratio of 0.26x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥278.33 Million) in capital expenditures (CN¥71.03 Million). Check 300142 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Walvax BioTech (2007–2025)
Capital reinvestment ratio of Walvax BioTech from 2007 to 2025. This chart tracks Walvax BioTech's Capital Reinvestment Ratio across 12 annual periods. Also explore net asset momentum of Walvax BioTech to track the company's year-over-year net asset growth rate.
Walvax BioTech Capital Reinvestment Ratio by Year (2007–2025)
Walvax BioTech capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see Walvax BioTech cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥494.37 Million | CN¥509.54 Million | ▲ +94.2% |
| 2024 | 0.53x | CN¥1.04 Billion | CN¥550.03 Million | ▼ -36.4% |
| 2023 | 0.83x | CN¥1.13 Billion | CN¥945.52 Million | ▼ -8.2% |
| 2022 | 0.91x | CN¥1.20 Billion | CN¥1.09 Billion | ▼ -42.0% |
| 2021 | 1.56x | CN¥705.28 Million | CN¥1.10 Billion | ▼ -56.1% |
| 2020 | 3.57x | CN¥114.19 Million | CN¥407.13 Million | ▼ -37.2% |
| 2019 | 5.67x | CN¥62.02 Million | CN¥351.82 Million | ▲ +24.9% |
| 2012 | 4.54x | CN¥78.38 Million | CN¥355.87 Million | ▲ +111.4% |
| 2011 | 2.15x | CN¥91.98 Million | CN¥197.56 Million | ▲ +13.0% |
| 2010 | 1.90x | CN¥86.71 Million | CN¥164.81 Million | ▲ +109.0% |
| 2009 | 0.91x | CN¥82.18 Million | CN¥74.75 Million | ▲ +58.7% |
| 2007 | 0.57x | CN¥31.85 Million | CN¥18.26 Million | — |